| Allied Chemi
Deliver to United Kingdom
0

HPLC column NUCLEODUR ® π 2 , 3 µm, 250 mm, 4 mm

£ 899.78*

*Prices plus VAT plus shipping costs

£ 1079.74*

*incl. VAT, plus shipping costs

HPLC column NUCLEODUR ® π 2 , 3 µm, 250 mm, 4 mm

Order number: 34TP.1

Part number: AC100008470

In Stock

Price Breakdown

1

6

24

Recommended for applications requiring controlled solvent behavior, such as antibiotics, particularly aromatic and unsaturated compounds, pharmaceutical products, especially for polar compounds, steroids, this HPLC column features a biphenylpropyl modified π 2 phase that offers an alternative selectivity compared to classical C 18 modifications. Based on high purity NUCLEODUR ® silica gel, it exhibits excellent performance under highly aqueous conditions, making it suitable for use with acetonitrile - water eluents. With a particle size of 3 μm and pressure stability up to 600 bar, this analytical separation column delivers reliable results at temperatures up to 60 ° C. Its specific surface area of 340 m²/g ensures efficient separations while maintaining its pH stability within the range of 3.0 - 10.0.

  • Category: Separation columns for HPLC
  • Pore volume: 0.9 ml/g
  • USP listing: L11
  • Column type: HPLC column
  • Column shape: Analytical separation column
  • Surface chemistry: Biphenylpropyl modification
  • Recommended application(s): Antibiotics Particularly aromatic and unsaturated compounds Pharmaceutical products Especially for polar compounds Steroids
  • Temperature stability: 60 ° C
  • Pore size: 110 Å
  • Separation principle: Reversed phase (RP)
  • Specific surface according to BET: 340 m²/g
  • Particle size: 3 µm
  • Particle type: Fully porous particles (FPP)
  • Eluent in column: Acetonitrile - Water
  • Endcapped: yes
  • Interactions / retention mechanism: π-π and hydrophobic
  • Pressure stability: 600 bar
  • pH stability: 3,0-10,0
  • Phase: π 2
  • L x Ø internal (column): 250 x 4 mm
allied chemi
  • secure-payment
  • visa
  • american-express
  • master-card

© 2026 Copyright. All Rights Reserved.